Financhill
Buy
58

TRVI Quote, Financials, Valuation and Earnings

Last price:
$4.59
Seasonality move :
58.97%
Day range:
$4.07 - $4.51
52-week range:
$1.27 - $4.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.68x
Volume:
1.3M
Avg. volume:
3M
1-year change:
235.38%
Market cap:
$335.1M
Revenue:
--
EPS (TTM):
-$0.44

Earnings Data

Next earnings date for TRVI
Mar 20
2025
Most recent earnings per share
-$0.13
Missed by $0.02
(Nov 6/2024)
Consensus Estimate
-$0.11
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TRVI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2025 Q1 -- -- -- -$0.12 --
03/20/2025 Q4 -- -- -- -$0.12 --
11/06/2024 Q3 -- -- -$0.13 -$0.11 -$0.02
08/08/2024 Q2 -- -- -$0.12 -$0.11 -$0.01
05/07/2024 Q1 -- -- -$0.11 -$0.09 -$0.02
03/20/2024 Q4 -- -- -$0.08 -$0.09 $0.01
11/09/2023 Q3 -- -- -$0.08 -$0.09 $0.01
08/10/2023 Q2 -- -- -$0.07 -$0.09 $0.02
05/11/2023 Q1 -- -- -$0.06 -$0.07 $0.01
03/16/2023 Q4 -- -- -$0.06 -$0.10 $0.04
11/10/2022 Q3 -- -- -$0.12 -$0.13 $0.01
08/11/2022 Q2 -- -- -$0.14 -$0.19 $0.05
05/12/2022 Q1 -- -- -$0.24 -$0.29 $0.05
03/17/2022 Q4 -- -- -$0.24 -$0.30 $0.06
11/10/2021 Q3 -- -- -$0.34 -$0.40 $0.06
08/12/2021 Q2 -- -- -$0.49 -$0.46 -$0.03
05/13/2021 Q1 -- -- -$0.43 -$0.52 $0.09
03/25/2021 Q4 -- -- -$0.51 -$0.44 -$0.07
11/11/2020 Q3 -- -- -$0.41 -$0.51 $0.10
08/12/2020 Q2 -- -- -$0.41 -$0.48 $0.07
05/07/2020 Q1 -- -- -$0.48 -$0.44 -$0.04
03/16/2020 Q4 -- -- -$0.37 -$0.51 $0.15
11/14/2019 Q3 -- -- -$0.41 -$0.48 $0.07
08/12/2019 Q2 -- -- -$0.41 -$0.42 $0.01
06/13/2019 Q1 -- -- -- -$0.52 --

Trevi Therapeutics Earnings Questions

  • How Much did Trevi Therapeutics Generate in Revenue Last Quarter?

    Trevi Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Trevi Therapeutics Beat Earnings Last Quarter?

    Trevi Therapeutics announced earnings per share of -$0.13 which represents a miss of analyst forecast a -$0.11 per share.

  • Is Trevi Therapeutics Profitable?

    Trevi Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Trevi Therapeutics EPS Next Year?

    Trevi Therapeutics's earnings are forecast to decrease from -$0.29 per share to -$0.48 per share next year representing a decrease of -68.97%.

  • When is Trevi Therapeutics's Earnings Date?

    Trevi Therapeutics's next earnings date is March 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Carlos Slim Buy PBF Energy?
Why Did Carlos Slim Buy PBF Energy?

Carlos Slim made a splash in a surprising sector last…

Is Booking Holdings Stock Undervalued?
Is Booking Holdings Stock Undervalued?

There is a lot of humdrum in the market about…

Broadcom vs American Express: Which Is Best?
Broadcom vs American Express: Which Is Best?

Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 116x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Sell
47
DRUG alert for Jan 3

Bright Minds Biosciences [DRUG] is down 4.28% over the past day.

Buy
88
BMA alert for Jan 3

Banco Macro SA [BMA] is up 0.88% over the past day.

Sell
50
AGFY alert for Jan 3

Agrify [AGFY] is down 5.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock